Shift work was associated with an increased risk for circadian syndrome but not metabolic syndrome among adults, especially those with evening work.

Current INSTI vs protease inhibitor or NNRTI use is linked to an increased risk for diabetes, which is slightly attenuated when adjusted for changes in BMI.

Tirzepatide for diabetes vs long-acting insulins demonstrated superior glycemic control and weight loss compared among adults with type 2 diabetes.

Sex hormone binding globulin changes were mediated by waist circumference among patients with type 2 diabetes receiving lifestyle intervention.

Levothyroxine treatment was associated with a reduced risk for major adverse cardiovascular events among patients with subclinical hypothyroidism.

The risk of heart attack and other adverse cardiovascular events is higher in patients with prostate cancer who have belly fat and reduced strength.

In patients with vs without history of incident heart failure hospitalization there is more rapid decline in global cognition.

Hypertension-related stroke risk can be decreased by lowering systolic BP to less than 140 mm Hg via aggressive pharmacological treatment.

Baseline small vessel disease score is the strongest predictor for incident infarcts among patients with a history of stroke.

The FDA has approved Flyrcado™ for positron emission tomography myocardial perfusion imaging under rest or stress in adult patients.

Social risk categories were associated with glycemic and quality of life-related outcomes among patients with type 2 diabetes.

Patients with both rheumatoid arthritis and atrial fibrillation (AF) vs AF only have a higher risk for ischemic stroke.